Search
for
Sort by
Research 22
- Hormonal manipulation of benign prostatic hyperplasia
- Slow progress in prostate cancer
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Targets to treat androgen excess in polycystic ovary syndrome
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Chapter 23. Therapeutic Control of Androgen Action
- Androgenic modulation of arterial baroreceptor dysfunction and neuroinflammation in endotoxic male rats
- Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes
- A Comprehensive Review of Management of Patients with Infertility having Polycystic Ovarian Syndrome
- Drug Repurposing Patent Applications July–September 2025
- Steroid Hormones of Reproduction and Sexual Development
- Men??s Health
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- Myo-Inositol (ProFecund Ino) – Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome
- ZALCITABINE